Brief: Pluristem Initiates Two Pivotal Phase III Studies In Israel
08/08/2018 12:23
Aug 8 (Reuters) - Pluristem Therapeutics Inc PSTI.O :
* PLURISTEM INITIATES TWO PIVOTAL PHASE III STUDIES IN
ISRAEL
* PLURISTEM THERAPEUTICS - BOTH TRIALS ACCEPTED TO
ACCELERATED
APPROVAL PATHWAYS
Source text for Eikon: ID:nGNX2qMKSn
Further company coverage: PSTI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Pluri
See all newsBrief: Pluri Chairman And Active Investor Alejandro Weinstein To Acquire Eib Loan, In Strong Vote Of Confidence In The Company
Brief: Ever After Foods Acquires Fishway To Expand Integrated Food Production Technology Platform
NASDAQ RESUMED AT 09:38 AM
NASDAQ RESUMED AT 09:33 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:33 AM